Arbutus Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	18.01	36.33	26.29	30.78	109.28
Short-Term Investments	73.46	86.29	99.72	116.14	46.04
Cash & Short-Term Investments	91.47	122.62	126	146.91	155.32
Cash Growth	-25.41%	-2.68%	-14.23%	-5.41%	26.00%
Accounts Receivable	1.45	2.41	1.78	1.35	0.9
Other Current Assets	1.54	2.28	4.25	2.87	4.45
Total Current Assets	94.46	127.32	132.03	151.14	160.66
Net Property, Plant & Equipment	0.03	4.36	6.09	6.81	8.08
Long-Term Investments	-	-	6.28	37.36	35.69
Other Long-Term Assets	0.13	0.03	-	0.1	0.06
Total Assets	94.62	131.71	144.4	195.42	204.49
Accounts Payable	5.46	7.56	10.27	16.03	10.84
Current Portion of Leases	0.55	0.48	0.43	0.37	0.38
Unearned Revenue	-	7.57	11.79	16.46	-
Total Current Liabilities	6.01	15.62	22.49	32.86	11.22
Long-Term Debt	3.44	4.83	6.95	10.37	16.3
Long-Term Leases	0.2	0.81	1.34	1.82	2.23
Other Long-Term Liabilities	8.4	13.09	7.6	13.53	5.3
Total Long-Term Liabilities	12.04	18.72	15.9	25.71	23.83
Total Liabilities	18.04	34.34	38.38	58.57	35.05
Common Stock	1,421	1,410	1,350	1,319	1,287
Additional Paid-in Capital	83.32	82.05	81.27	72.41	65.49
Accumulated Other Comprehensive Income	-48.1	-48.14	-48.42	-50.49	-48.34
Retained Earnings	-1,380	-1,347	-1,277	-1,204	-1,134
Shareholders' Equity	76.58	97.37	106.02	136.85	169.44
Total Liabilities & Equity	94.62	131.71	144.4	195.42	204.49
Total Debt	4.19	6.12	8.72	12.55	18.91
Net Cash (Debt)	87.28	116.51	117.28	134.36	136.41
Net Cash Growth	-25.08%	-0.66%	-12.71%	-1.50%	35.42%
Net Cash Per Share	0.46	0.63	0.71	0.89	1.28
Book Value	76.58	97.37	106.02	136.85	169.44
Book Value Per Share	0.40	0.52	0.64	0.91	1.59
Tangible Book Value	76.58	97.37	106.02	136.85	169.44
Tangible Book Value Per Share	0.40	0.52	0.64	0.91	1.59

Updated Mar 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q